Floatz logo

GLUCAGON-LIKE PEPTIDE 1, HUMAN

GLP-1

Haukeland University Hospitalprotein_peptideActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the GLP-1 cohort.

Asset / SponsorPhaseRating
Semaglutide
Anders Fink-Jensen, MD, DMSci
Phase 4BB

Same molecule, other indications

GLUCAGON-LIKE PEPTIDE 1, HUMAN is also rated in:

polycystic ovary syndromeDormant
CCC
Indicative ·
53 / 100
View asset →
type 2 diabetes mellitusDormant
CC
Indicative ·
42 / 100
View asset →
obesity disorderDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →